incretins

News

Oura has launched a trial to see if data collected from its smart rings can help scientists understand physiological changes with obesity treatment.

News

Eli Lilly has added another arrow to the quiver of new diabetes and obesity drug retatrutide, outperforming Novo's Ozempic in a head-to-head trial.

News

Novo continues to build the case for its new weight-loss candidate CagriSema, pointing to new data that show strong efficacy in women.

News

The list of illnesses that may benefit from treatment with GLP-1 drugs gets ever longer, and a study has found that schizophrenia may be an addition.

News

A study has shown that the efficacy of Lilly's psoriasis therapy Taltz is improved when it is given in combination with weight-loss drug Zepbound.

News

Online pharmacies operating in the UK breached Advertising Standards Authority rules by promoting oral weight drugs to the public.